UPDATE: On August 1, 2017, a $300 million Benicar settlement was reached with the drug makers to resolve certain claims for injuries stemming from use of Benicar, Benicar HCT, Azor or Tribenzor prior to May 2015. Saiontz & Kirk, P.A. is longer reviewing new cases. The… Read More
UPDATE: On August 1, 2017, a $300 million Benicar settlement was reached with the drug makers to resolve certain claims for injuries stemming from use of Benicar, Benicar HCT, Azor or Tribenzor prior to May 2015. Saiontz & Kirk, P.A. is longer reviewing new cases. The… Read More
Over the past decade, millions of people have used the hypertension drugs Benicar, Azor and Tribenzor, which all contain the active ingredient olmesartan. Last year, the FDA required the Daiichi Sankyo and Forest Laboratories to add new warnings about the risk of serious and potentially life-threatening… Read More
For years, side effects of Benicar have caused users to experience symptoms similar to celiac disease, with chronic diarrhea, weight loss and other severe gastrointestinal problems. (more…) Read More
The product liability lawyers at Saiontz & Kirk, P.A. are launching a television commercial for Benicar lawsuits, providing a legal alert for users of Benicar who have suffered chronic diarrhea or other gastrointestinal problems. (more…) Read More
The hypertension drug Benicar was on the market for more than 10 years before the first warnings were provided about the risk of sprue-like enteropathy. As a result many users have experienced chronic diarrhea from Benicar and other drugs containing olmesartan, often resulting in permanent gastrointestinal… Read More
UPDATE: On August 1, 2017, a $300 million Benicar settlement was reached with the drug makers to resolve certain claims for injuries stemming from use of Benicar, Benicar HCT, Azor or Tribenzor prior to May 2015. Saiontz & Kirk, P.A. is longer reviewing new cases. The… Read More
